Here are the recipes we’re whipping up this month to get dinner on the table, entertain our friends, satisfy a sweet tooth, use up leftovers, and everything in between. For even more staff favorites, ...

Glacier National Park's decision to implement timed ticketed entry next summer drew mixed reviews from visitors and stakeholders, though officials say it will help further reduce congestion. The ...

Morton was a physician and naturalist who lived in Philadelphia from 1799 until the end of his life in 1851. A lecture he delivered to aspiring doctors at the Philadelphia Association for Medical ...

"It's scary times," said Maribel Hernández Rivera, his wife and an immigration attorney by trade. She's also the director of policy and government affairs for the ACLU, whose affiliate helped bring ...

The Health and Social Care Secretary spoke at the NHS Providers annual conference 2024, in Salford. I've come along today to ...

Ah, Maine – the land of lighthouses, lobster, and… luscious tacos? That’s right, folks. Just when you thought you had this ...

NEW YORK — U.S. stocks drifted to a mixed finish Wednesday after the latest inflation update boosted hopes that more help for the economy will arrive next month through a cut to interest rates.

Main St., was demolished this week, and the site developer said the $30 million six-story mixed-use project is moving forward. Jackie Fahey, Chief Operating Officer for Land Ventures in ...

HONG KONG — European markets opened higher on Wednesday while Asian stocks followed Wall Street lower as momentum cooled for the torrid “Trump trade” that swept U.S. markets following Donald ...

Send us your thoughts: [email protected] and [email protected]. Holders of Chinese equities got mixed news on Friday. At the National Peoples’ Congress meeting, the government ...

A recent episode of Bigg Boss 18 sparked controversy online when Alice Kaushik and Avinash Mishra were shown cuddling in bed. While some criticized their actions, citing Alice's relationship ...

The company posted an earnings per share loss of $0.25. Development progress reported for key drugs, including brepocitinib and batoclimab. Increased operational expenses and reduced cash reserves ...